Prior to Velomedix, Mr. Gold was a Venture Partner for Longitude Capital where he focused on investments in medical devices. From 2001-2005 he was Chief Executive Officer of CryoVascular Systems, a medical device company developing treatments for peripheral vascular disease. CryoVascular was acquired by Boston Scientific Corporation in 2005. From 1997 to 2000, Mr. Gold was COO and Executive Vice President of CardioThoracic Systems (NASDAQ: CTSI), a medical device company focused on developing products to enable off-pump open-heart surgery. CTSI was acquired by Guidant Corporation. Prior to CTSI, Mr. Gold spent 18 years with Cordis Corporation, now the primary cardiovascular device subsidiary of Johnson & Johnson, in a series of roles of increasing responsibility and scope. He was co-founder and President of Cordis Endovascular Systems, the subsidiary company that initially focused on the interventional neuroradiology and peripheral markets. Mr. Gold holds an MBA from the University of Florida and a BS in Engineering from Northeastern University and is a graduate of GE’s Manufacturing Management Program.
Mr. Bohane has 20 years of experience in Finance, Accounting and Administration, primarily with small start-up companies. Before joining Velomedix, Mr. Bohane was CFO at Sadra Medical and SquareOne, Inc., VP of Finance & Administration at AccessClosure, Inc., and Director of Finance & Administration at Embolic Protection, Inc. He was Controller at XL Construction for six years prior to that. Mr. Bohane earned his BS in Business (Finance/Economics) from San Jose State University.
Dr. Ivanhoe joined Velomedix as a consultant in April 2012 and then as the Chief Medical Officer in August of 2013. Prior to joining Velomedix, Dr. Ivanhoe was the founding CEO of Vida Systems, Inc. a medical education software company developing game-based surgical training systems and interactive health education software. From 2004-2011, Dr. Ivanhoe was Chief Medical Officer at Paracor Medical, Inc., a venture-backed heart failure device company. And from 2002-2004, Dr. Ivanhoe served as a consultant to Guidant Compass Group, Medtronic and Apollo Capital Group. From 1989-2000 Dr. Ivanhoe was an interventional cardiologist with the Florida Heart Group and the Florida Heart Institute, based in Orlando. During this time, Dr. Ivanhoe was a Partner and Lead Interventional Cardiologist where he was an early investigator in STEMI and stent development. Dr. Ivanhoe holds his BS, with Honors, from UC Santa Cruz, his Doctor of Medicine degree from Chicago Medical School, and an MBA from the University of Chicago, Booth School of Business.
Ms. Bebeau joined Velomedix in November 2012. Ms. Bebeau has more than 18 years of experience in the planning and execution of drug and medical device trials across multiple geographies. From 2005 to 2012, Ms. Bebeau served as Senior Clinical Director for the St Jude Medical Cardiovascular and International Divisions where she was responsible for several IDEs, PMAs, and post market programs supporting regulatory approvals and physician adoption in the United States, Canada, Europe, Australia, and Japan. This clinical research experience included heart valves (both open heart and percutaneous), vascular access and closure devices, FFR, and OCT. Prior to her tenure at St Jude Medical, Ms. Bebeau served in various clinical leadership roles at Boston Scientific and Medtronic. Ms. Bebeau holds a BSN from Bethel College and is a licensed Registered Nurse.
Mr. Buehlmann has been with Velomedix since 2008 where he has played a leading role in product development and helping Velomedix initiate its clinical trials. Prior to joining Velomedix, Eric Buehlmann developed numerous products at various early stage medical device companies, bringing these devices from concept to clinical use and commercialization. These devices, including electromechanical systems, span the fields of Cardiology, Orthopedics, and Oncology. Mr. Buehlmann holds a BS from the University of the Pacific and is a licensed Professional Engineer (PE).
Mr. Moore joined Velomedix in January 2012. From 2008 to 2011, Mr. Moore served as VP Operations for MRI Interventions, a medical device company developing MRI – guided interventional solutions. Mr. Moore has 18 years of experience in medical device development and product realization. From January 2003 to March 2008, he was the Chief Technical Officer for Bolton Medical, Inc. In addition, Mr. Moore previously served as Director of R&D and Operations for Medtronic AVE, and performed various roles in operations and product development at Cordis Corporation and DePuy Orthopedics. He holds a BS in Mechanical Engineering from Purdue University.